US$ 24.35
semaglutide alcohol aversion Medscape | Once weekly injections reduced consumption in patients with alcohol use disorder and comorbid obesity. Results of the Ozempic and Wegovy may help
Description
Conditions being studied Scientists are looking at how GLP1 agonists impact: Progression of diabetic retinopathy , a diabetes-related eye disease that can cause blurriness and blindness While initial studies indicated that diabetic retinopathy could worsen while taking this medication, more recent, large-scale data suggests that there is no increased risk

For more details regarding LoCITT, including how to participate in this or subsequent trials, please visit The study team will host a webinar on November 5, 2025, 11 a.m

Only the SSA can do that
Many report that being on GLP-1 drugs reduces their level of food noise. With fewer intrusive thoughts about food, its easier to make balanced choices

Licensed independent medical providers determine whether treatment is appropriate

"Others find it quite profound, their favourite foods no longer spark joy, or they realise theyre no longer thinking about food all the time." Dr Alex Craven, a Melbourne-based upper gastrointestinal and bariatric surgeon, adds: "This isnt entirely new